DGX – Quest Diagnostics Incorporated
Float Short %
5.28
Margin Of Safety %
22
Put/Call OI Ratio
0.98
EPS Next Q Diff
-0.23
EPS Last/This Y
2.03
EPS This/Next Y
0.57
Price
182.19
Target Price
199.5
Analyst Recom
2.27
Performance Q
-1.34
Relative Volume
1.66
Beta
0.65
Ticker: DGX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-26 | DGX | 175.97 | 0.45 | 0.09 | 8411 |
| 2025-12-29 | DGX | 175.51 | 0.45 | 0.05 | 8419 |
| 2025-12-30 | DGX | 175.56 | 0.45 | 0.27 | 8377 |
| 2025-12-31 | DGX | 173.45 | 0.45 | 4.17 | 8443 |
| 2026-01-02 | DGX | 173.7 | 0.66 | 0.45 | 9607 |
| 2026-01-05 | DGX | 173.41 | 0.66 | 0.65 | 9639 |
| 2026-01-06 | DGX | 180.42 | 0.67 | 0.15 | 9697 |
| 2026-01-07 | DGX | 178.15 | 0.66 | 0.51 | 9771 |
| 2026-01-08 | DGX | 177.79 | 0.67 | 1.85 | 9788 |
| 2026-01-09 | DGX | 174.47 | 0.81 | 0.25 | 10635 |
| 2026-01-12 | DGX | 175.9 | 0.81 | 0.25 | 10652 |
| 2026-01-13 | DGX | 179.92 | 0.82 | 0.72 | 10568 |
| 2026-01-14 | DGX | 186.74 | 0.82 | 0.02 | 10447 |
| 2026-01-15 | DGX | 190.21 | 0.72 | 0.75 | 11249 |
| 2026-01-16 | DGX | 189.52 | 0.72 | 1.05 | 11325 |
| 2026-01-20 | DGX | 189.38 | 0.89 | 0.57 | 9422 |
| 2026-01-21 | DGX | 184.62 | 0.88 | 15.05 | 9521 |
| 2026-01-22 | DGX | 182.27 | 0.98 | 3.75 | 10057 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-26 | DGX | 175.96 | 5.7 | 210.4 | 9.81 |
| 2025-12-29 | DGX | 175.54 | 5.7 | 206.9 | 9.81 |
| 2025-12-30 | DGX | 175.45 | 5.7 | 209.5 | 9.81 |
| 2025-12-31 | DGX | 173.44 | 5.7 | 194.1 | 9.81 |
| 2026-01-02 | DGX | 173.73 | 5.7 | 211.6 | 9.81 |
| 2026-01-05 | DGX | 173.46 | 5.7 | 207.4 | 9.81 |
| 2026-01-06 | DGX | 180.48 | 5.7 | 264.9 | 9.81 |
| 2026-01-07 | DGX | 178.15 | 5.7 | 192.5 | 9.81 |
| 2026-01-08 | DGX | 177.79 | 5.8 | 207.4 | 9.81 |
| 2026-01-09 | DGX | 174.43 | 5.8 | 184.6 | 9.81 |
| 2026-01-12 | DGX | 175.90 | 5.8 | 221.5 | 9.81 |
| 2026-01-13 | DGX | 180.07 | 5.8 | 242.0 | 9.81 |
| 2026-01-14 | DGX | 186.73 | 5.8 | 261.7 | 9.81 |
| 2026-01-15 | DGX | 190.23 | 5.8 | 235.7 | 9.81 |
| 2026-01-16 | DGX | 189.49 | 5.8 | 204.4 | 9.81 |
| 2026-01-20 | DGX | 189.03 | 5.8 | 206.7 | 9.81 |
| 2026-01-21 | DGX | 184.52 | 5.8 | 177.6 | 9.81 |
| 2026-01-22 | DGX | 182.19 | 5.8 | 191.7 | 9.81 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-26 | DGX | -18.86 | -1.19 | 3.82 |
| 2025-12-29 | DGX | -18.86 | -1.15 | 3.82 |
| 2025-12-30 | DGX | -18.86 | -1.15 | 3.82 |
| 2025-12-31 | DGX | -18.86 | -1.15 | 3.82 |
| 2026-01-02 | DGX | -18.86 | -1.15 | 3.82 |
| 2026-01-05 | DGX | -18.86 | -1.13 | 3.82 |
| 2026-01-06 | DGX | -18.86 | -1.13 | 3.82 |
| 2026-01-07 | DGX | -18.86 | -1.13 | 3.82 |
| 2026-01-08 | DGX | -18.86 | -1.13 | 3.82 |
| 2026-01-09 | DGX | -18.86 | -1.13 | 3.82 |
| 2026-01-12 | DGX | -18.58 | -0.92 | 3.82 |
| 2026-01-13 | DGX | -18.86 | -0.92 | 5.28 |
| 2026-01-14 | DGX | -18.86 | -0.92 | 5.28 |
| 2026-01-15 | DGX | -18.86 | -0.92 | 5.28 |
| 2026-01-16 | DGX | -18.86 | -0.92 | 5.28 |
| 2026-01-20 | DGX | -18.86 | -0.85 | 5.28 |
| 2026-01-21 | DGX | -18.86 | -0.85 | 5.28 |
| 2026-01-22 | DGX | -18.86 | -0.85 | 5.28 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
2.6
Avg. EPS Est. Current Quarter
2.36
Avg. EPS Est. Next Quarter
2.37
Insider Transactions
-18.86
Institutional Transactions
-0.85
Beta
0.65
Average Sales Estimate Current Quarter
2753
Average Sales Estimate Next Quarter
2760
Fair Value
221.93
Quality Score
74
Growth Score
84
Sentiment Score
66
Actual DrawDown %
7.8
Max Drawdown 5-Year %
-28.6
Target Price
199.5
P/E
21.38
Forward P/E
17.55
PEG
2.18
P/S
1.87
P/B
2.79
P/Free Cash Flow
14.55
EPS
8.52
Average EPS Est. Cur. Y
9.81
EPS Next Y. (Est.)
10.38
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
8.88
Relative Volume
1.66
Return on Equity vs Sector %
-14
Return on Equity vs Industry %
2.4
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
191.7
Quest Diagnostics IncorporatedSector: Healthcare
Industry: Diagnostics & Research
Employees: 45000
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
stock quote shares DGX – Quest Diagnostics Incorporated Stock Price stock today
news today DGX – Quest Diagnostics Incorporated stock forecast ,stock prediction 2023 2024 2025
marketwatch DGX – Quest Diagnostics Incorporated yahoo finance google finance
stock history DGX – Quest Diagnostics Incorporated invest stock market
stock prices DGX premarket after hours
ticker DGX fair value insiders trading